Astrotech (ASTC) – Press Releases
-
Astrotech Announces Listing to the GSA as an Approved United States Government Vendor
-
Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference
-
Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000
-
Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results
-
IBN Coverage Initiated for Astrotech Corp.
-
Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary
-
Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems
-
Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results
-
1ST DETECT SECURES SIGNIFICANT PURCHASE ORDER FOR ADDITIONAL CHECKPOINT SECURITY UNITS
-
LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company’s Innovative Product Pipeline Continues to Grow (Updated with Additional Details)
-
Astrotech Reports Fiscal Year 2023 Financial Results
-
ASTROTECH BOARD UNANIMOUSLY REJECTS UNSOLICITED ACQUISITION PROPOSAL FROM BML INVESTMENT PARTNERS, L.P.
-
ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL
-
Astrotech Reports Third Quarter of Fiscal Year 2023 Financial Results
-
ASTROTECH ANNOUNCES CONFIRMED AGLAB, INC. FIELD TRIAL RESULTS
-
1ST DETECT SECURES SIGNIFICANT PURCHASE ORDER FOR CHECKPOINT SECURITY
-
Astrotech Reports Second Quarter of Fiscal Year 2023 Financial Results
-
Astrotech Appoints Thomas B. Pickens III as Chief Technology Officer
-
Astrotech Appoints Thomas B. Pickens III as Chief Technology Officer
-
ASTROTECH APPOINTS BOB MCFARLAND TO BOARD OF DIRECTORS
-
ASTROTECH APPOINTS BOB MCFARLAND TO BOARD OF DIRECTORS
-
ASTROTECH ADOPTS LIMITED-DURATION STOCKHOLDER RIGHTS PLAN
-
ASTROTECH ADOPTS LIMITED-DURATION STOCKHOLDER RIGHTS PLAN
-
ASTROTECH REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS
-
ASTROTECH REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS
-
ASTROTECH ANNOUNCES REVERSE STOCK SPLIT
-
ASTROTECH ANNOUNCES REVERSE STOCK SPLIT
-
ASTROTECH CORPORATION Announces Advancement in Detection of Lung Infections
-
ASTROTECH CORPORATION Announces Advancement in Detection of Lung Infections
-
ASTROTECH LAUNCHES THE AgLAB-1000-D2 MAXIMUM VALUE PROCESSING CONTROL SYSTEM
-
ASTROTECH LAUNCHES THE AgLAB-1000-D2 MAXIMUM VALUE PROCESSING CONTROL SYSTEM
-
Astrotech Reports First Quarter of Fiscal Year 2023 Financial Results
-
Astrotech Reports Fiscal Year 2022 Financial Results
-
Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
-
Astrotech Appoints Jim Becker to Board of Directors
-
Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases
-
Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as Its Chief Science Officer
-
Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder Proposals
-
Astrotech Begins Search for Strategic Acquisitions
-
Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Reports Fiscal Year 2021 Financial Results
-
1st Detect Lands First Purchase Order for Checkpoint Security
-
Astrotech Hires Industry Veteran Joe Levinthal to Lead AgLAB’s Science Team
-
Astrotech Reports Third Quarter of Fiscal Year 2021 Financial Results
-
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million
-
Astrotech Announces $10 Million Bought Deal Offering of Common Stock
-
Astrotech Subsidiary and Cleveland Clinic Sign Agreement for Breath Analysis Study to Develop a Rapid COVID-19 Breath Test
Back to ASTC Stock Lookup
